// App-Quantinova.ai

OA09.03 : Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

Researchers

Presenter

  • S. Gadgeel

Principal Investigators

  • M. Nagasaka

  • T. Braun

  • H. Cheng

  • A. Wozniak

  • J. Stevenson

  • P. Patil

  • A. Qin

  • Z. Niu

Medical Centers

  • Cleveland Clinic, Cleveland, OH

  • University of Michigan, Ann Arbor, MI

  • Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

  • Rush University Medical Center, Chicago, IL

  • Karmanos Cancer Institute, Wayne State University, Detroit, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Programmed death-ligand 1

Drug/Treatment

  • Pembrolizumab

  • Carboplatin

  • Pemetrexed

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved